게놈 검사 시장 : 검사 유형별, 질환별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Genome Testing Market size was valued at USD 8,954.2 Million in 2023, expanding at a CAGR of 22.50% from 2024 to 2032.

DNA testing has several medical uses, including infant DNA screening, identity diagnostics and forensics, pre-natal DNA carrier screening, infectious disease diagnostics, oncology histopathology and diagnostics, and so on. Genetic testing involves the use of hair, blood, skin, and other samples. Depending on the suspected ailment, the sample is sent to a lab, where researchers look for specific proteins, DNA, or chromosome changes. Kits and panels are used in DNA testing to detect diseases in humans. Human blood samples are collected for DNA testing, and the tests are performed using test kits and lab equipment.

Genome Testing Market- Market Dynamics

Growing Need for DNA Testing in Various Applications

Diagnostic testing is used to identify or rule out a specific genetic or chromosomal abnormality. When physical signs and symptoms point to a problem, genetic testing is commonly used to confirm the diagnosis. Although diagnostic testing is not available for every gene or genetic condition, it can be performed prior to birth or at any time during an individual's life. A diagnostic test's results may influence decisions about medical care and disease management. DNA sequences are employed in forensic testing to identify individuals for legal purposes. This testing can be used to establish biological relationships between persons, identify victims of crime or tragedy, exclude or implicate a criminal suspect, and so on.

Genome Testing Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of approximately 22.50% from 2024 to 2032.

Based on Test Type segmentation, the diagnostic testing sector accounted for the biggest revenue share in 2023.

Based on Disease segmentation, in 2023, cancer will dominate the market.

Based on region, North America was the leading revenue generator in 2023

Genome Testing Market- Segmentation Analysis:

The Global Genome Testing Market is segmented based on Test Type, Disease, and Region.

The market is divided into seven categories based on Test Type: Carrier Testing, Predictive Testing, Diagnostic Testing, Prenatal & Newborn Testing, Nutrigenomics, Pharmacogenomics and Others. The diagnostic testing segment dominated the worldwide genetic testing market in terms of revenue in 2023 and is expected to maintain its dominance during the forecast period. This is simply due to the rising frequency of chronic diseases in the worldwide population. According to a survey, almost 60% of the US population suffers from at least one chronic condition. Furthermore, the rapidly rising elderly population and increased need for diagnostic tests among them have propelled the segment's expansion in recent years.

The market is divided into seven categories based on Diseases: Cancer, Alzheimer's, Thalassemia, Cystic Fibrosis, Huntington's Disease, Duchenne Muscular Dystrophy, and Other Diseases. The cancer category controlled the global genetic testing market in terms of revenue in 2023 and is expected to maintain its dominance during the forecast period. This is simply due to the rising prevalence of cancer in the global population. The rising prevalence of cancers such as breast cancer, lung cancer, bowel cancer, and womb cancer are the primary drivers of this category.

Genome Testing Market- Geographical Insights

Geographically, this market is present in North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These zones are further split based on which countries bring business. North America dominated the global genetic testing market in terms of revenue in 2023, and its dominance is expected to continue during the forecast period. This can be due to growing consumer knowledge of the benefits of genetic testing in the general population. Furthermore, the widespread availability of self-testing kits via online websites in countries such as the United States has increased the population's use of genetic testing kits. Furthermore, the rising prevalence of chronic diseases among the majority of the population, combined with higher consumer spending on healthcare, has accelerated market expansion. The growing senior population in the United States is likely to drive the market in the coming years.

Asia Pacific is the fastest-growing market due to the vast target population in China, India, South Korea, and Japan. Furthermore, one of the primary drivers of market expansion is the growing use of modern laboratory techniques and techniques, such as DNA sequencing, for rapid examination and diagnosis of chronic and infectious ailments.

Genome Testing Market- Competitive Landscape:

In the Genome Testing Market Competitive Landscape, several companies compete to provide advanced genome testing services and products. Genentech Inc., Sorenson Genomics, LLC, Abbott Molecular, Bayer Diagnostics, and Biocartis are among the leading companies producing cutting-edge genome sequencing and analysis technology. These organizations aim to stay competitive by investing in R&D, creating strategic alliances, and introducing novel testing solutions. Understanding the competitive environment can provide useful insights into market dynamics, allowing organizations to make informed decisions in the genomic testing industry.

Recent Developments:

In January 2022, ARCHIMED Life formed a strategic agreement with Amides Holding GmbH to increase and improve access to unique diagnostic services for genetic, biochemical, and biomarker testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL GENOME TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Genentech Inc.

Sorenson Genomics, LLC

Abbott Molecular

Bayer Diagnostics

Biocartis

BioHelix

Celera Genomics

Genomic Health

HTG Molecular Diagnostics

PacBio

Others

GLOBAL GENOME TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

• Carrier Testing
• Predictive Testing
• Diagnostic Testing
• Prenatal & Newborn Testing
• Nutrigenomics
• Pharmacogenomics
• Others

GLOBAL GENOME TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

• Cancer
• Alzheimer's
• Thalassemia
• Cystic Fibrosis
• Huntington's Disease
• Duchenne Muscular Dystrophy
• Other Diseases

GLOBAL GENOME TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Genome Testing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Genome Testing Market Snippet by Test Type
  • 2.1.2. Genome Testing Market Snippet by Disease
  • 2.1.3. Genome Testing Market Snippet by Country
  • 2.1.4. Genome Testing Market Snippet by Region
• 2.2. Competitive Insights

3. Genome Testing Key Market Trends

• 3.1. Genome Testing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Genome Testing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Genome Testing Market Opportunities
• 3.4. Genome Testing Market Future Trends

4. Genome Testing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Genome Testing Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Genome Testing Market Landscape

• 6.1. Genome Testing Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Genome Testing Market - By Test Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
  • 7.1.2. Carrier Testing
  • 7.1.3. Predictive Testing
  • 7.1.4. Diagnostic Testing
  • 7.1.5. Prenatal & Newborn Testing
  • 7.1.6. Nutrigenomics
  • 7.1.7. Pharmacogenomics
  • 7.1.8. Others

8. Genome Testing Market - By Disease

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
  • 8.1.2. Cancer
  • 8.1.3. Alzheimer's
  • 8.1.4. Thalassemia
  • 8.1.5. Cystic Fibrosis
  • 8.1.6. Huntington's Disease
  • 8.1.7. Duchenne Muscular Dystrophy
  • 8.1.8. Other Diseases

9. Genome Testing Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Genome Testing Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Genome Testing Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Genome Testing Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Genome Testing Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Genome Testing Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Genome Testing Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Genentech Inc.
  • 10.2.2. Sorenson Genomics, LLC
  • 10.2.3. Abbott Molecular
  • 10.2.4. Bayer Diagnostics
  • 10.2.5. Biocartis
  • 10.2.6. BioHelix
  • 10.2.7. Celera Genomics
  • 10.2.8. Genomic Health
  • 10.2.9. HTG Molecular Diagnostics
  • 10.2.10. PacBio
  • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us